The Mount Sinai Discovery and Innovation Center, located on Manhattan’s West Side, will expand medical and biotech research in collaboration with clinical neuroscience and neurosurgery centers of excellence.
“The new center will be a rich environment for innovation, bringing together leading experts in the fields of genomics and stem cell science, neuroscience, and immunology, all in one location,” said Dennis Charney, MD, the health system’s president for academic affairs, in an Oct. 5 news release.
Researchers will also focus on gene editing, proteomics, and dermatology. The facility “incorporates design elements to provide Mount Sinai healthcare and research employees with a new, vibrant work environment,” stated Reginald Miller, senior research integrity officer at Mount Sinai Health System.
“We anticipate the center to bring in large and diverse sets of data, providing researchers with a wide depth of information to deliver better care for patients,” stated Eric Nestler, MD, PhD, the system’s chief scientific officer.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
